News

With an already wide-ranging portfolio of institutional research facilities, which included Cambridge’s own Genzyme Center, the first building of its size to earn LEED Platinum certification ...
Sanofi Genzyme’s Northboro Global Operations Center, a 212,000-square-foot life sciences building in Northboro, sold for $33 million last month.
Wheelock Street Capital is entering the biomanufacturing market with a $33M purchase of a Sanofi Genzyme plant west of Boston.
Under his mentorship, the Genzyme teams chose to forgo the traditional blockbuster approach to innovation and instead put patients at the center of their strategy. They focused on the development of ...
Sanofi, the French pharmaceutical giant that acquired Genzyme seven years ago, said Wednesday that it will be laying off 95 workers at its Framingham manufacturing site.
Genzyme received a $14.3 million grant from the Massachusetts Life Sciences Center – part of former Gov. Deval Patrick’s $1 billion Life Sciences Initiative – to upgrade sewer infrastructure ...
Genzyme received a $14.3 million grant from the Massachusetts Life Sciences Center – part of former Gov. Deval Patrick’s $1 billion Life Sciences Initiative – to upgrade sewer infrastructure ...
Shire signed a 12-year lease for the building that was formerly known as the Genzyme Center.
Drug maker Shire PLC will expand its Kendall Square footprint in Cambridge by leasing the building known as the Genzyme Center to create a rare disease “innovation hub.” The company signed a ...
The Genzyme global operations and distribution center in Northborough has been sold to a Chicago investment company for $20.875 million.
Mohammed Almannai, M.D., and Juanita Neira of Baylor College of Medicine were honored as the 2016-2017 recipients of the Sanofi Genzyme/ACMG Foundation Medical Genetics Training Award in Clinical ...
Genzyme, a Sanofi company, announced today that selected artwork from Expression of Hope III will be featured through a travelling exhibit and online gallery. Expression of Hope is a global ...